Investing

XOMA Royalty : XOMA

XOMA

Stock Data

$44.20

$0.60 (1.34%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

XOMA Corp is a pioneering biotech royalty aggregator with a global presence, including Europe, the United States, and the Asia Pacific. Founded in 1981 and based in Emeryville, California, XOMA plays a crucial role in advancing human health by acquiring future economic rights of pre-commercial therapeutic candidates. The company specializes in identifying and investing in early to mid-stage clinical assets, particularly those in Phase 1 and 2, which show promise for commercial success. XOMA's diverse portfolio underscores its commitment to fostering innovation in the biotech industry.

All XOMA Royalty Articles

27 Articles

Trey Thoelcke | Dec 12, 2025 at 8:45 AM EST

Huge Insider Buying in MGM and Salesforce

As the year winds down, insiders make huge buys in MGM Resorts and Salesforce. However, those were not the only…

Lee Jackson | Jun 29, 2021 at 1:16 PM EDT

Stem, Tesla, Textron, Two Harbors and More Tuesday Afternoon Analyst Calls

Oasis Petroleum, Stem, Tata Motors, Tesla, Textron and Two Harbors Investment were among Tuesday afternoon's analyst upgrades and downgrades.

Jon C. Ogg | Oct 17, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Biogen, Carbonite, Celgene, Emerson Electric, Kinder Morgan, Netflix, UnitedHealth and Many More

The top analyst upgrades, downgrades and other research calls from Tuesday include Biogen, Carbonite, Celgene, Emerson Electric, Kinder Morgan, Netflix…

Jon C. Ogg | Sep 5, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Chesapeake Energy, Lululemon, Oracle, US Steel, Disney, YogaWorks and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Chesapeake Energy, Lululemon Athletica, Oracle, US Steel, Walt…

Chris Lange | Dec 5, 2016 at 1:05 PM EST

10 Major Pharma and FDA Catalysts Coming in December

24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.

Jon C. Ogg | Nov 14, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades After Election: Ciena, CME Group, Energy Transfer, NVIDIA, US Steel and Many More

The top analyst upgrades, downgrades and initiations seen on Monday morning include Ciena, CME Group, Energy Transfer, NVIDIA and U.S.…

Chris Lange | Nov 7, 2015 at 9:25 AM EST

5 BioPharma Movers That Cannot Be Ignored

Last week, a few biotech companies made absolutely massive runs, while others had serious falls.

Lee Jackson | Jul 25, 2015 at 9:15 AM EDT

Insiders Heavily Dump Former High-Flyer Biotech Stock

One thing all biotech investors know is that if a binary event like clinical data goes wrong on a company…

Jon C. Ogg | Jul 23, 2015 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Boeing, EMC, Hertz, Qualcomm, SanDisk, Twitter, XOMA and More

Thursday's top analyst upgrades, downgrades and initiations include Boeing, EMC, Hertz, Qualcomm, SanDisk, Twitter and XOMA.

Chris Lange | Jul 22, 2015 at 11:05 AM EDT

Is This the End for XOMA?

XOMA Corp. (NASDAQ: XOMA) stumbled in trading Wednesday morning, perhaps fell off a cliff might be more accurate.

Lee Jackson | May 1, 2015 at 8:20 AM EDT

3 Biotech Stocks With Big Phase 3 Catalyst Data Due in 2015

Recently, biotech stocks have been getting stung pretty good, and now may be a good time to look at companies…

Lee Jackson | Jan 22, 2015 at 9:15 AM EST

3 Biotech Stocks With Upcoming Data That Could Be Huge

A new report from RBC focuses on top small-cap biotech stocks with key data readouts coming in 2015. Binary events…

Lee Jackson | Jan 10, 2015 at 9:10 AM EST

Insider Buying Dominates First Full Week of Trading in 2015

The steep sell-off at the start of the week certainly enticed some insiders to step up to the plate and…

Lee Jackson | Jan 3, 2015 at 9:10 AM EST

Insiders Sell High-Profile Stocks as 2014 Trading Comes to an End

With the 2014 trading year coming to an end last week, the pace of inside selling picked up a bit…

Lee Jackson | Dec 27, 2014 at 9:10 AM EST

Tech Insiders Sell Shares as Markets Hit All-Time Highs

In a week when the markets were putting in some all-time highs, many insiders stayed on the sidelines, which is…